In treatment of type 2 diabetes mellitus with emphasis on reduced calorie intake and more physical activity, the patient’s weight can stagnate or even rise.
However, therapy can be successful if fat decreases and muscle increases. With help from a medical body composition analyser, the SECA mBCA, diabetologists are able to determine the patient’s fat and muscle mass development with greater precision. Four international studies have provided evidence of its benefits, comparing the diagnostic device with scientific gold standards. In the non-invasive bioelectrical impedance measurement, which takes less than 20 seconds, fat mass, water and skeletal muscle mass are determined and the data presented in an understandable, user-friendly form.
